ONTOLOGY	ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
KEGG	hsa04512	ECM-receptor interaction	7/112	88/8135	0.0001969	0.04391	0.03979	ITGB3/ITGA2B/IBSP/DSPP/GP1BB/GP9/ITGB5	7
KEGG	hsa04510	Focal adhesion	10/112	201/8135	0.0004289	0.04782	0.04334	MYL9/ITGB3/ITGA2B/IBSP/EGF/MYLK/ITGB5/CAV2/VCL/PDGFA	10
KEGG	hsa04611	Platelet activation	7/112	124/8135	0.001557	0.1125	0.102	ITGB3/ITGA2B/GP1BB/GP9/GNAS/MYLK/PTGS1	7
KEGG	hsa05207	Chemical carcinogenesis - receptor activation	9/112	212/8135	0.002522	0.1125	0.102	UGT2B11/PTGES3/MIR29C/EGF/GNAS/RXRB/CYP1A1/UGT1A1/MIR29B1	9
KEGG	hsa05204	Chemical carcinogenesis - DNA adducts	5/112	69/8135	0.002523	0.1125	0.102	UGT2B11/CYP2C18/CYP1A1/UGT1A1/CYP2E1	5
KEGG	hsa04810	Regulation of actin cytoskeleton	9/112	218/8135	0.003043	0.1131	0.1025	MYL9/ITGB3/ITGA2B/EGF/MYLK/ITGB5/VCL/PDGFA/GNG12	9
KEGG	hsa00983	Drug metabolism - other enzymes	5/112	80/8135	0.00479	0.1526	0.1383	UGT2B11/UPB1/UPP2/UGT1A1/CYP2E1	5
KEGG	hsa04630	JAK-STAT signaling pathway	7/112	162/8135	0.006882	0.1755	0.1591	CDKN1A/FHL1/PIM1/EGF/MPL/PDGFA/SOCS3	7
KEGG	hsa04540	Gap junction	5/112	88/8135	0.00716	0.1755	0.1591	TUBB1/EGF/GNAS/GJA1/PDGFA	5
KEGG	hsa00053	Ascorbate and aldarate metabolism	3/112	30/8135	0.00787	0.1755	0.1591	UGT2B11/UGT1A1/RGN	3
KEGG	hsa00140	Steroid hormone biosynthesis	4/112	61/8135	0.00973	0.1972	0.1788	UGT2B11/CYP1A1/UGT1A1/CYP2E1	4
KEGG	hsa05418	Fluid shear stress and atherosclerosis	6/112	139/8135	0.01218	0.2263	0.2051	CALM3/ITGB3/ITGA2B/CAV2/PDGFA/PRKAA2	6
KEGG	hsa00830	Retinol metabolism	4/112	68/8135	0.01411	0.2421	0.2194	UGT2B11/CYP2C18/CYP1A1/UGT1A1	4
KEGG	hsa04921	Oxytocin signaling pathway	6/112	154/8135	0.01932	0.276	0.2502	MYL9/CALM3/CDKN1A/GNAS/MYLK/PRKAA2	6
KEGG	hsa05214	Glioma	4/112	75/8135	0.01959	0.276	0.2502	CALM3/CDKN1A/EGF/PDGFA	4
KEGG	hsa04726	Serotonergic synapse	5/112	115/8135	0.02098	0.276	0.2502	CYP2C18/GNG11/GNAS/PTGS1/GNG12	5
KEGG	hsa05412	Arrhythmogenic right ventricular cardiomyopathy	4/112	77/8135	0.02136	0.276	0.2502	ITGB3/ITGA2B/GJA1/ITGB5	4
KEGG	hsa00980	Metabolism of xenobiotics by cytochrome P450	4/112	78/8135	0.02228	0.276	0.2502	UGT2B11/CYP1A1/UGT1A1/CYP2E1	4
KEGG	hsa04151	PI3K-Akt signaling pathway	10/112	354/8135	0.02368	0.2779	0.2518	ITGB3/CDKN1A/ITGA2B/IBSP/GNG11/EGF/ITGB5/PDGFA/PRKAA2/GNG12	10
KEGG	hsa04146	Peroxisome	4/112	82/8135	0.02621	0.2922	0.2649	AMACR/PEX12/CRAT/PEX14	4
KEGG	hsa04012	ErbB signaling pathway	4/112	85/8135	0.02941	0.2982	0.2702	CDKN1A/EGF/BTC/NRG1	4
KEGG	hsa04610	Complement and coagulation cascades	4/112	85/8135	0.02941	0.2982	0.2702	F13A1/CLU/PROS1/C3	4
KEGG	hsa05410	Hypertrophic cardiomyopathy	4/112	90/8135	0.03525	0.3306	0.2996	ITGB3/ITGA2B/ITGB5/PRKAA2	4
KEGG	hsa05032	Morphine addiction	4/112	91/8135	0.03649	0.3306	0.2996	GABRA3/GNG11/GNAS/GNG12	4
KEGG	hsa04270	Vascular smooth muscle contraction	5/112	134/8135	0.03726	0.3306	0.2996	MYL9/CALM3/CALD1/GNAS/MYLK	5
KEGG	hsa04740	Olfactory transduction	11/112	440/8135	0.03932	0.3306	0.2996	OR2T27/OR13C2/CALM3/OR51D1/OR5M10/OR2AJ1/OR52N2/OR5P3/OR4N5/OR9Q1/OR10K2	11
KEGG	hsa04371	Apelin signaling pathway	5/112	139/8135	0.04255	0.3306	0.2996	CALM3/GNG11/MYLK/PRKAA2/GNG12	5
KEGG	hsa05414	Dilated cardiomyopathy	4/112	96/8135	0.04308	0.3306	0.2996	ITGB3/ITGA2B/GNAS/ITGB5	4
KEGG	hsa05134	Legionellosis	3/112	57/8135	0.04347	0.3306	0.2996	HSPA1L/CLK1/C3	3
KEGG	hsa04713	Circadian entrainment	4/112	97/8135	0.04448	0.3306	0.2996	CALM3/GNG11/GNAS/GNG12	4
KEGG	hsa04640	Hematopoietic cell lineage	4/112	99/8135	0.04734	0.3405	0.3086	ITGB3/ITGA2B/GP1BB/GP9	4
KEGG	hsa00590	Arachidonic acid metabolism	3/112	61/8135	0.05142	0.3584	0.3248	PTGES3/PTGS1/CYP2E1	3
KEGG	hsa01240	Biosynthesis of cofactors	5/112	153/8135	0.05967	0.4032	0.3654	UGT2B11/PTS/UGT1A1/RGN/GGCX	5
KEGG	hsa05205	Proteoglycans in cancer	6/112	205/8135	0.06328	0.4151	0.3762	ITGB3/CDKN1A/CTTN/ITGB5/CAV2/MIR21	6
KEGG	hsa05160	Hepatitis C	5/112	157/8135	0.06519	0.4154	0.3764	CLDN8/CDKN1A/EIF2AK1/EGF/SOCS3	5
KEGG	hsa04920	Adipocytokine signaling pathway	3/112	69/8135	0.06927	0.4166	0.3776	RXRB/PRKAA2/SOCS3	3
KEGG	hsa04015	Rap1 signaling pathway	6/112	210/8135	0.06941	0.4166	0.3776	CALM3/ITGB3/ITGA2B/EGF/GNAS/PDGFA	6
KEGG	hsa04670	Leukocyte transendothelial migration	4/112	114/8135	0.07198	0.4166	0.3776	MYL9/CLDN8/ESAM/VCL	4
KEGG	hsa00982	Drug metabolism - cytochrome P450	3/112	72/8135	0.0766	0.4166	0.3776	UGT2B11/UGT1A1/CYP2E1	3
KEGG	hsa05218	Melanoma	3/112	72/8135	0.0766	0.4166	0.3776	CDKN1A/EGF/PDGFA	3
KEGG	hsa05223	Non-small cell lung cancer	3/112	72/8135	0.0766	0.4166	0.3776	CDKN1A/EGF/RXRB	3
KEGG	hsa00040	Pentose and glucuronate interconversions	2/112	34/8135	0.07926	0.4208	0.3814	UGT2B11/UGT1A1	2
KEGG	hsa04530	Tight junction	5/112	169/8135	0.08342	0.4326	0.3921	MYL9/CLDN8/CTTN/PRKAA2/AMOTL1	5
KEGG	hsa04971	Gastric acid secretion	3/112	76/8135	0.08687	0.4349	0.3942	CALM3/GNAS/MYLK	3
KEGG	hsa05100	Bacterial invasion of epithelial cells	3/112	77/8135	0.08953	0.4349	0.3942	CTTN/CAV2/VCL	3
KEGG	hsa05163	Human cytomegalovirus infection	6/112	225/8135	0.08979	0.4349	0.3942	CALM3/ITGB3/CDKN1A/GNG11/GNAS/GNG12	6
KEGG	hsa05216	Thyroid cancer	2/112	37/8135	0.09166	0.4349	0.3942	CDKN1A/RXRB	2
KEGG	hsa01521	EGFR tyrosine kinase inhibitor resistance	3/112	79/8135	0.09494	0.4411	0.3997	EGF/NRG1/PDGFA	3
KEGG	hsa04728	Dopaminergic synapse	4/112	132/8135	0.1086	0.4861	0.4406	CALM3/GNG11/GNAS/GNG12	4
KEGG	hsa05219	Bladder cancer	2/112	41/8135	0.109	0.4861	0.4406	CDKN1A/EGF	2
KEGG	hsa00860	Porphyrin metabolism	2/112	43/8135	0.118	0.5116	0.4637	UGT2B11/UGT1A1	2
KEGG	hsa04910	Insulin signaling pathway	4/112	137/8135	0.12	0.5116	0.4637	CALM3/PRKAR2B/PRKAA2/SOCS3	4
KEGG	hsa04727	GABAergic synapse	3/112	89/8135	0.1239	0.5116	0.4637	GABRA3/GNG11/GNG12	3
KEGG	hsa04976	Bile secretion	3/112	89/8135	0.1239	0.5116	0.4637	UGT2B11/GNAS/UGT1A1	3
KEGG	hsa05167	Kaposi sarcoma-associated herpesvirus infection	5/112	194/8135	0.129	0.5158	0.4674	CALM3/CDKN1A/GNG11/C3/GNG12	5
KEGG	hsa00920	Sulfur metabolism	1/112	10/8135	0.1295	0.5158	0.4674	SUOX	1
KEGG	hsa05222	Small cell lung cancer	3/112	92/8135	0.1331	0.519	0.4704	CDKN1A/ITGA2B/RXRB	3
KEGG	hsa05206	MicroRNAs in cancer	7/112	310/8135	0.135	0.519	0.4704	MIR29C/ITGB3/CDKN1A/PIM1/PDGFA/MIR29B1/MIR21	7
KEGG	hsa00130	Ubiquinone and other terpenoid-quinone biosynthesis	1/112	11/8135	0.1415	0.523	0.474	GGCX	1
KEGG	hsa05150	Staphylococcus aureus infection	3/112	96/8135	0.1458	0.523	0.474	SELP/C3/DEFB4B	3
KEGG	hsa04723	Retrograde endocannabinoid signaling	4/112	148/8135	0.1468	0.523	0.474	GABRA3/GNG11/NDUFS8/GNG12	4
KEGG	hsa05215	Prostate cancer	3/112	97/8135	0.1491	0.523	0.474	CDKN1A/EGF/PDGFA	3
KEGG	hsa04925	Aldosterone synthesis and secretion	3/112	98/8135	0.1523	0.523	0.474	CALM3/GNAS/MC2R	3
KEGG	hsa05231	Choline metabolism in cancer	3/112	98/8135	0.1523	0.523	0.474	EGF/PCYT1B/PDGFA	3
KEGG	hsa00330	Arginine and proline metabolism	2/112	51/8135	0.1555	0.523	0.474	ODC1/ARG2	2
KEGG	hsa04913	Ovarian steroidogenesis	2/112	51/8135	0.1555	0.523	0.474	GNAS/CYP1A1	2
KEGG	hsa04145	Phagosome	4/112	152/8135	0.1571	0.523	0.474	ITGB3/TUBB1/ITGB5/C3	4
KEGG	hsa05012	Parkinson disease	6/112	266/8135	0.16	0.5248	0.4756	CALM3/TUBB1/NDUFS8/GNAS/SNCAIP/SNCA	6
KEGG	hsa04932	Non-alcoholic fatty liver disease	4/112	155/8135	0.165	0.5275	0.4781	NDUFS8/PRKAA2/SOCS3/CYP2E1	4
KEGG	hsa05146	Amoebiasis	3/112	102/8135	0.1656	0.5275	0.4781	GNAS/VCL/ARG2	3
KEGG	hsa05165	Human papillomavirus infection	7/112	331/8135	0.171	0.5371	0.4868	ITGB3/CDKN1A/ITGA2B/IBSP/EGF/GNAS/ITGB5	7
KEGG	hsa05417	Lipid and atherosclerosis	5/112	215/8135	0.1745	0.5405	0.4898	CALM3/HSPA1L/RXRB/SELP/CYP1A1	5
KEGG	hsa04928	Parathyroid hormone synthesis, secretion and action	3/112	106/8135	0.1792	0.5423	0.4914	CDKN1A/GNAS/RXRB	3
KEGG	hsa04923	Regulation of lipolysis in adipocytes	2/112	56/8135	0.1799	0.5423	0.4914	GNAS/PTGS1	2
KEGG	hsa04922	Glucagon signaling pathway	3/112	107/8135	0.1826	0.543	0.4921	CALM3/GNAS/PRKAA2	3
KEGG	hsa00240	Pyrimidine metabolism	2/112	58/8135	0.1899	0.5499	0.4984	UPB1/UPP2	2
KEGG	hsa05213	Endometrial cancer	2/112	58/8135	0.1899	0.5499	0.4984	CDKN1A/EGF	2
KEGG	hsa04022	cGMP-PKG signaling pathway	4/112	167/8135	0.198	0.5643	0.5114	MYL9/CALM3/PDE5A/MYLK	4
KEGG	hsa04730	Long-term depression	2/112	60/8135	0.1999	0.5643	0.5114	GNAZ/GNAS	2
KEGG	hsa04724	Glutamatergic synapse	3/112	114/8135	0.2072	0.5713	0.5178	GNG11/GNAS/GNG12	3
KEGG	hsa04213	Longevity regulating pathway - multiple species	2/112	62/8135	0.21	0.5713	0.5178	HSPA1L/PRKAA2	2
KEGG	hsa00120	Primary bile acid biosynthesis	1/112	17/8135	0.2101	0.5713	0.5178	AMACR	1
KEGG	hsa00310	Lysine degradation	2/112	63/8135	0.215	0.5713	0.5178	PLOD2/EZH1	2
KEGG	hsa04014	Ras signaling pathway	5/112	232/8135	0.2152	0.5713	0.5178	CALM3/GNG11/EGF/PDGFA/GNG12	5
KEGG	hsa04927	Cortisol synthesis and secretion	2/112	65/8135	0.2252	0.5908	0.5355	GNAS/MC2R	2
KEGG	hsa04020	Calcium signaling pathway	5/112	240/8135	0.2353	0.6102	0.553	CALM3/EGF/GNAS/MYLK/PDGFA	5
KEGG	hsa04924	Renin secretion	2/112	69/8135	0.2456	0.622	0.5637	CALM3/GNAS	2
KEGG	hsa05031	Amphetamine addiction	2/112	69/8135	0.2456	0.622	0.5637	CALM3/GNAS	2
KEGG	hsa00770	Pantothenate and CoA biosynthesis	1/112	21/8135	0.2529	0.622	0.5637	UPB1	1
KEGG	hsa05034	Alcoholism	4/112	187/8135	0.2567	0.622	0.5637	CALM3/GNG11/GNAS/GNG12	4
KEGG	hsa04926	Relaxin signaling pathway	3/112	129/8135	0.262	0.622	0.5637	GNG11/GNAS/GNG12	3
KEGG	hsa00220	Arginine biosynthesis	1/112	22/8135	0.2632	0.622	0.5637	ARG2	1
KEGG	hsa04144	Endocytosis	5/112	251/8135	0.2638	0.622	0.5637	DAB2/ZFYVE27/HSPA1L/CAV2/ASAP2	5
KEGG	hsa04613	Neutrophil extracellular trap formation	4/112	190/8135	0.2658	0.622	0.5637	ITGB3/ITGA2B/SELP/C3	4
KEGG	hsa04068	FoxO signaling pathway	3/112	131/8135	0.2695	0.622	0.5637	CDKN1A/EGF/PRKAA2	3
KEGG	hsa04062	Chemokine signaling pathway	4/112	192/8135	0.2719	0.622	0.5637	PPBP/GNG11/PF4/GNG12	4
KEGG	hsa03060	Protein export	1/112	23/8135	0.2733	0.622	0.5637	SPCS2	1
KEGG	hsa04614	Renin-angiotensin system	1/112	23/8135	0.2733	0.622	0.5637	CTSA	1
KEGG	hsa05133	Pertussis	2/112	76/8135	0.2815	0.6276	0.5688	CALM3/C3	2
KEGG	hsa05212	Pancreatic cancer	2/112	76/8135	0.2815	0.6276	0.5688	CDKN1A/EGF	2
KEGG	hsa04915	Estrogen signaling pathway	3/112	138/8135	0.2958	0.6531	0.5919	CALM3/HSPA1L/GNAS	3
KEGG	hsa00790	Folate biosynthesis	1/112	26/8135	0.303	0.6561	0.5946	PTS	1
KEGG	hsa04950	Maturity onset diabetes of the young	1/112	26/8135	0.303	0.6561	0.5946	HNF4G	1
KEGG	hsa04936	Alcoholic liver disease	3/112	142/8135	0.3109	0.6667	0.6042	C3/PRKAA2/CYP2E1	3
KEGG	hsa01232	Nucleotide metabolism	2/112	85/8135	0.3273	0.6779	0.6143	GMPR/UPP2	2
KEGG	hsa00591	Linoleic acid metabolism	1/112	29/8135	0.3315	0.6779	0.6143	CYP2E1	1
KEGG	hsa04744	Phototransduction	1/112	29/8135	0.3315	0.6779	0.6143	CALM3	1
KEGG	hsa05210	Colorectal cancer	2/112	86/8135	0.3324	0.6779	0.6143	CDKN1A/EGF	2
KEGG	hsa04072	Phospholipase D signaling pathway	3/112	148/8135	0.3336	0.6779	0.6143	EGF/GNAS/PDGFA	3
KEGG	hsa04514	Cell adhesion molecules	3/112	149/8135	0.3374	0.6779	0.6143	CLDN8/SELP/ESAM	3
KEGG	hsa05226	Gastric cancer	3/112	149/8135	0.3374	0.6779	0.6143	CDKN1A/EGF/RXRB	3
KEGG	hsa00030	Pentose phosphate pathway	1/112	30/8135	0.3407	0.6784	0.6149	RGN	1
KEGG	hsa04211	Longevity regulating pathway	2/112	89/8135	0.3475	0.6784	0.6149	ATG101/PRKAA2	2
KEGG	hsa00410	beta-Alanine metabolism	1/112	31/8135	0.3499	0.6784	0.6149	UPB1	1
KEGG	hsa04710	Circadian rhythm	1/112	31/8135	0.3499	0.6784	0.6149	PRKAA2	1
KEGG	hsa04136	Autophagy - other	1/112	32/8135	0.3588	0.6796	0.6159	ATG101	1
KEGG	hsa04934	Cushing syndrome	3/112	155/8135	0.3601	0.6796	0.6159	CDKN1A/GNAS/MC2R	3
KEGG	hsa04024	cAMP signaling pathway	4/112	221/8135	0.3625	0.6796	0.6159	MYL9/CALM3/GNAS/MC2R	4
KEGG	hsa04912	GnRH signaling pathway	2/112	93/8135	0.3675	0.6796	0.6159	CALM3/GNAS	2
KEGG	hsa04970	Salivary secretion	2/112	93/8135	0.3675	0.6796	0.6159	CALM3/GNAS	2
KEGG	hsa05208	Chemical carcinogenesis - reactive oxygen species	4/112	223/8135	0.3688	0.6796	0.6159	NDUFS8/EGF/CYP1A1/CYP2E1	4
KEGG	hsa04070	Phosphatidylinositol signaling system	2/112	97/8135	0.3872	0.7021	0.6363	CALM3/PI4K2A	2
KEGG	hsa01522	Endocrine resistance	2/112	98/8135	0.3921	0.7021	0.6363	CDKN1A/GNAS	2
KEGG	hsa04750	Inflammatory mediator regulation of TRP channels	2/112	98/8135	0.3921	0.7021	0.6363	CALM3/GNAS	2
KEGG	hsa00350	Tyrosine metabolism	1/112	36/8135	0.3936	0.7021	0.6363	HGD	1
KEGG	hsa04061	Viral protein interaction with cytokine and cytokine receptor	2/112	100/8135	0.4018	0.7111	0.6445	PPBP/PF4	2
KEGG	hsa04916	Melanogenesis	2/112	101/8135	0.4067	0.714	0.6471	CALM3/GNAS	2
KEGG	hsa05142	Chagas disease	2/112	102/8135	0.4115	0.7169	0.6497	GNAS/C3	2
KEGG	hsa05033	Nicotine addiction	1/112	40/8135	0.4264	0.7372	0.6681	GABRA3	1
KEGG	hsa04931	Insulin resistance	2/112	108/8135	0.44	0.7456	0.6757	PRKAA2/SOCS3	2
KEGG	hsa00380	Tryptophan metabolism	1/112	42/8135	0.4422	0.7456	0.6757	CYP1A1	1
KEGG	hsa05131	Shigellosis	4/112	247/8135	0.4437	0.7456	0.6757	MYL9/CTTN/C3/VCL	4
KEGG	hsa04066	HIF-1 signaling pathway	2/112	109/8135	0.4447	0.7456	0.6757	CDKN1A/EGF	2
KEGG	hsa04962	Vasopressin-regulated water reabsorption	1/112	44/8135	0.4575	0.7595	0.6883	GNAS	1
KEGG	hsa04360	Axon guidance	3/112	182/8135	0.46	0.7595	0.6883	MYL9/ABLIM3/EPHB2	3
KEGG	hsa04725	Cholinergic synapse	2/112	113/8135	0.4632	0.7595	0.6883	GNG11/GNG12	2
KEGG	hsa04930	Type II diabetes mellitus	1/112	46/8135	0.4724	0.769	0.697	SOCS3	1
KEGG	hsa04935	Growth hormone synthesis, secretion and action	2/112	119/8135	0.4903	0.7814	0.7082	GNAS/SOCS3	2
KEGG	hsa05030	Cocaine addiction	1/112	49/8135	0.4941	0.7814	0.7082	GNAS	1
KEGG	hsa05202	Transcriptional misregulation in cancer	3/112	193/8135	0.4989	0.7814	0.7082	CDKN1A/RXRB/PDGFA	3
KEGG	hsa04919	Thyroid hormone signaling pathway	2/112	121/8135	0.4991	0.7814	0.7082	ITGB3/RXRB	2
KEGG	hsa05110	Vibrio cholerae infection	1/112	50/8135	0.5011	0.7814	0.7082	GNAS	1
KEGG	hsa05144	Malaria	1/112	50/8135	0.5011	0.7814	0.7082	SELP	1
KEGG	hsa05130	Pathogenic Escherichia coli infection	3/112	197/8135	0.5127	0.7921	0.7179	CLDN8/TUBB1/CTTN	3
KEGG	hsa04961	Endocrine and other factor-regulated calcium reabsorption	1/112	53/8135	0.5215	0.7921	0.7179	GNAS	1
KEGG	hsa05020	Prion disease	4/112	273/8135	0.5217	0.7921	0.7179	TUBB1/NDUFS8/HSPA1L/CAV2	4
KEGG	hsa05168	Herpes simplex virus 1 infection	7/112	495/8135	0.5271	0.7921	0.7179	SRSF5/ITGB3/EIF2AK1/ZNF33A/C3/SOCS3/ZNF674	7
KEGG	hsa00230	Purine metabolism	2/112	128/8135	0.5292	0.7921	0.7179	GMPR/PDE5A	2
KEGG	hsa04380	Osteoclast differentiation	2/112	128/8135	0.5292	0.7921	0.7179	ITGB3/SOCS3	2
KEGG	hsa04340	Hedgehog signaling pathway	1/112	56/8135	0.5411	0.7985	0.7237	SPOP	1
KEGG	hsa04114	Oocyte meiosis	2/112	131/8135	0.5418	0.7985	0.7237	CALM3/SPDYA	2
KEGG	hsa04142	Lysosome	2/112	132/8135	0.5459	0.7985	0.7237	CTSA/CLN5	2
KEGG	hsa00480	Glutathione metabolism	1/112	58/8135	0.5538	0.7985	0.7237	ODC1	1
KEGG	hsa05170	Human immunodeficiency virus 1 infection	3/112	212/8135	0.5626	0.7985	0.7237	CALM3/GNG11/GNG12	3
KEGG	hsa04978	Mineral absorption	1/112	60/8135	0.5661	0.7985	0.7237	STEAP1	1
KEGG	hsa05162	Measles	2/112	139/8135	0.5741	0.7985	0.7237	EIF2AK1/HSPA1L	2
KEGG	hsa04010	MAPK signaling pathway	4/112	294/8135	0.5809	0.7985	0.7237	EGF/HSPA1L/PDGFA/GNG12	4
KEGG	hsa04140	Autophagy - animal	2/112	141/8135	0.5819	0.7985	0.7237	ATG101/PRKAA2	2
KEGG	hsa03250	Viral life cycle - HIV-1	1/112	63/8135	0.5839	0.7985	0.7237	MAP1A	1
KEGG	hsa05217	Basal cell carcinoma	1/112	63/8135	0.5839	0.7985	0.7237	CDKN1A	1
KEGG	hsa04120	Ubiquitin mediated proteolysis	2/112	142/8135	0.5858	0.7985	0.7237	RHOBTB1/SOCS3	2
KEGG	hsa00970	Aminoacyl-tRNA biosynthesis	1/112	66/8135	0.601	0.7985	0.7237	HARS2	1
KEGG	hsa03040	Spliceosome	2/112	147/8135	0.6048	0.7985	0.7237	SRSF5/HSPA1L	2
KEGG	hsa05224	Breast cancer	2/112	147/8135	0.6048	0.7985	0.7237	CDKN1A/EGF	2
KEGG	hsa04720	Long-term potentiation	1/112	67/8135	0.6065	0.7985	0.7237	CALM3	1
KEGG	hsa05221	Acute myeloid leukemia	1/112	67/8135	0.6065	0.7985	0.7237	PIM1	1
KEGG	hsa05010	Alzheimer disease	5/112	384/8135	0.6149	0.7985	0.7237	CALM3/TUBB1/NDUFS8/ATG101/SNCA	5
KEGG	hsa04261	Adrenergic signaling in cardiomyocytes	2/112	150/8135	0.6159	0.7985	0.7237	CALM3/GNAS	2
KEGG	hsa05211	Renal cell carcinoma	1/112	69/8135	0.6173	0.7985	0.7237	CDKN1A	1
KEGG	hsa04917	Prolactin signaling pathway	1/112	70/8135	0.6227	0.7985	0.7237	SOCS3	1
KEGG	hsa04714	Thermogenesis	3/112	232/8135	0.6242	0.7985	0.7237	NDUFS8/GNAS/PRKAA2	3
KEGG	hsa05171	Coronavirus disease - COVID-19	3/112	232/8135	0.6242	0.7985	0.7237	F13A1/SELP/C3	3
KEGG	hsa04520	Adherens junction	1/112	71/8135	0.6279	0.7985	0.7237	VCL	1
KEGG	hsa04218	Cellular senescence	2/112	156/8135	0.6373	0.7985	0.7237	CALM3/CDKN1A	2
KEGG	hsa00562	Inositol phosphate metabolism	1/112	73/8135	0.6382	0.7985	0.7237	PI4K2A	1
KEGG	hsa01524	Platinum drug resistance	1/112	73/8135	0.6382	0.7985	0.7237	CDKN1A	1
KEGG	hsa04115	p53 signaling pathway	1/112	73/8135	0.6382	0.7985	0.7237	CDKN1A	1
KEGG	hsa05022	Pathways of neurodegeneration - multiple diseases	6/112	476/8135	0.6469	0.7985	0.7237	CALM3/TUBB1/NDUFS8/SNCAIP/ATG101/SNCA	6
KEGG	hsa01230	Biosynthesis of amino acids	1/112	75/8135	0.6481	0.7985	0.7237	ARG2	1
KEGG	hsa03320	PPAR signaling pathway	1/112	75/8135	0.6481	0.7985	0.7237	RXRB	1
KEGG	hsa04918	Thyroid hormone synthesis	1/112	75/8135	0.6481	0.7985	0.7237	GNAS	1
KEGG	hsa05220	Chronic myeloid leukemia	1/112	76/8135	0.653	0.8001	0.7252	CDKN1A	1
KEGG	hsa05140	Leishmaniasis	1/112	77/8135	0.6579	0.8017	0.7265	C3	1
KEGG	hsa04612	Antigen processing and presentation	1/112	78/8135	0.6626	0.8031	0.7278	HSPA1L	1
KEGG	hsa04141	Protein processing in endoplasmic reticulum	2/112	171/8135	0.6868	0.8278	0.7503	EIF2AK1/HSPA1L	2
KEGG	hsa04742	Taste transduction	1/112	86/8135	0.6984	0.8328	0.7548	GABRA3	1
KEGG	hsa04911	Insulin secretion	1/112	86/8135	0.6984	0.8328	0.7548	GNAS	1
KEGG	hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	1/112	89/8135	0.7108	0.8421	0.7632	EGF	1
KEGG	hsa05152	Tuberculosis	2/112	180/8135	0.7137	0.8421	0.7632	CALM3/C3	2
KEGG	hsa04350	TGF-beta signaling pathway	1/112	94/8135	0.7304	0.8521	0.7722	LTBP1	1
KEGG	hsa04657	IL-17 signaling pathway	1/112	94/8135	0.7304	0.8521	0.7722	DEFB4B	1
KEGG	hsa03015	mRNA surveillance pathway	1/112	97/8135	0.7415	0.8521	0.7722	PAPOLG	1
KEGG	hsa04666	Fc gamma R-mediated phagocytosis	1/112	97/8135	0.7415	0.8521	0.7722	ASAP2	1
KEGG	hsa05014	Amyotrophic lateral sclerosis	4/112	364/8135	0.7449	0.8521	0.7722	TUBB1/NDUFS8/NRG1/ATG101	4
KEGG	hsa00564	Glycerophospholipid metabolism	1/112	98/8135	0.7451	0.8521	0.7722	PCYT1B	1
KEGG	hsa04933	AGE-RAGE signaling pathway in diabetic complications	1/112	100/8135	0.7521	0.8548	0.7747	PIM1	1
KEGG	hsa04914	Progesterone-mediated oocyte maturation	1/112	102/8135	0.759	0.8548	0.7747	SPDYA	1
KEGG	hsa04972	Pancreatic secretion	1/112	102/8135	0.759	0.8548	0.7747	GNAS	1
KEGG	hsa04625	C-type lectin receptor signaling pathway	1/112	104/8135	0.7657	0.858	0.7776	CALM3	1
KEGG	hsa05203	Viral carcinogenesis	2/112	204/8135	0.7764	0.8594	0.7789	CDKN1A/C3	2
KEGG	hsa04060	Cytokine-cytokine receptor interaction	3/112	295/8135	0.7782	0.8594	0.7789	PPBP/MPL/PF4	3
KEGG	hsa04659	Th17 cell differentiation	1/112	108/8135	0.7785	0.8594	0.7789	RXRB	1
KEGG	hsa04668	TNF signaling pathway	1/112	112/8135	0.7906	0.8642	0.7832	SOCS3	1
KEGG	hsa05145	Toxoplasmosis	1/112	112/8135	0.7906	0.8642	0.7832	HSPA1L	1
KEGG	hsa05016	Huntington disease	3/112	306/8135	0.799	0.8652	0.7841	TUBB1/NDUFS8/ATG101	3
KEGG	hsa01200	Carbon metabolism	1/112	115/8135	0.7992	0.8652	0.7841	RGN	1
KEGG	hsa04722	Neurotrophin signaling pathway	1/112	119/8135	0.8102	0.8698	0.7883	CALM3	1
KEGG	hsa04152	AMPK signaling pathway	1/112	120/8135	0.8129	0.8698	0.7883	PRKAA2	1
KEGG	hsa05166	Human T-cell leukemia virus 1 infection	2/112	222/8135	0.8152	0.8698	0.7883	CDKN1A/MMP7	2
KEGG	hsa04110	Cell cycle	1/112	126/8135	0.828	0.8793	0.7969	CDKN1A	1
KEGG	hsa00190	Oxidative phosphorylation	1/112	134/8135	0.8464	0.8945	0.8107	NDUFS8	1
KEGG	hsa05322	Systemic lupus erythematosus	1/112	136/8135	0.8506	0.8948	0.8109	C3	1
KEGG	hsa05132	Salmonella infection	2/112	249/8135	0.8623	0.901	0.8166	MYL9/TUBB1	2
KEGG	hsa05017	Spinocerebellar ataxia	1/112	143/8135	0.8647	0.901	0.8166	ATG101	1
KEGG	hsa04080	Neuroactive ligand-receptor interaction	3/112	353/8135	0.8706	0.903	0.8184	GABRA3/C3/MC2R	3
KEGG	hsa04150	mTOR signaling pathway	1/112	156/8135	0.8874	0.9161	0.8303	PRKAA2	1
KEGG	hsa05161	Hepatitis B	1/112	162/8135	0.8965	0.9213	0.835	CDKN1A	1
KEGG	hsa04310	Wnt signaling pathway	1/112	167/8135	0.9036	0.9213	0.835	MMP7	1
KEGG	hsa05225	Hepatocellular carcinoma	1/112	168/8135	0.905	0.9213	0.835	CDKN1A	1
KEGG	hsa05164	Influenza A	1/112	171/8135	0.9089	0.9213	0.835	SOCS3	1
KEGG	hsa04621	NOD-like receptor signaling pathway	1/112	184/8135	0.9242	0.9326	0.8452	DEFB4B	1
KEGG	hsa05169	Epstein-Barr virus infection	1/112	202/8135	0.9413	0.9422	0.8539	CDKN1A	1
KEGG	hsa05415	Diabetic cardiomyopathy	1/112	203/8135	0.9422	0.9422	0.8539	NDUFS8	1